• linkedin
  • Increase Font
  • Sharebar

    9 Newly Approved Novel Drugs

    It's been a busy year for the FDA.


    Man in wheelchair

    3. Emflaza (deflazacort), Marathon Pharmaceuticals

    Indication: A corticosteroid approved for treatment of Duchenne muscular dystrophy, the most common form of muscular dystrophy, in patients five years of age or older.

    Dosage: Oral dosage approximately 0.9 mg/kg/day once daily; for oral suspension round up to the nearest tenth of a milliliter.

    Contraindications: Known hypersensitivity to deflazacort or to any inactive ingredients.

    Read our coverage of this drug and troubles with its pricing here

    Read the full prescribing information here

    Previous ButtonNext Button



    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available